Â鶹ÊÓƵ

Skip to content
Find a Provider
Ruth M. O'Regan, M.D.

Ruth M. O'Regan, M.D.

Hematology & Oncology , Cancer

No ratings currently available, see text in Ratings section below for explanation.

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Appointment (585) 487-1700
Administrative (585) 275-8538

Locations

Pluta Cancer Center - Henrietta

Red Creek (Calkins Corporate Park)
125 Red Creek Drive
Rochester, NY 14623

Wilmot Cancer Center - Rochester

Strong Memorial Hospital
90 Crittenden Boulevard
Rochester, NY 14642

(585) 275-5830

About Me

Dr. Ruth O'Regan, M.D., is the Chair of Medicine and Charles A. Dewey Professor at the University of Rochester. She additionally serves as Physician-in-Chief of Strong Memorial Hospital and as Associate Director of Education and Mentoring at the Wilmot Cancer Institute at University of Rochester....
Dr. Ruth O'Regan, M.D., is the Chair of Medicine and Charles A. Dewey Professor at the University of Rochester. She additionally serves as Physician-in-Chief of Strong Memorial Hospital and as Associate Director of Education and Mentoring at the Wilmot Cancer Institute at University of Rochester.

She previously was Division Chief of Hematology, Medical Oncology and Palliative Care in the Department of Medicine and as Deputy Director at the Carbone Cancer Center at the University of Wisconsin School of Medicine and Public Health (UWSMPH). She served as Chief Scientific officer of the Big Ten Cancer Research Consortium guiding the research and scientific mission of the consortium and as Vice-Chair of the National Comprehensive Cancer Network Board of Directors. Prior to joining the faculty at UWSMPH she was Director of the Glenn Family Breast Cancer Program at the Winship Cancer Institute and as Vice-Chair for Education and Director of the Hematology Oncology Fellowship program in the Department of Hematology and Medical Oncology at Emory University. She additionally served as Chief of Hematology and Medical Oncology at the Georgia Cancer Center for Excellence at Grady Memorial Hospital.

Dr. O'Regan earned her Medical Degree from University College, Dublin, Ireland and completed her Internal Medicine residency at the Medical College of Wisconsin and her Hematology/Oncology fellowship at Northwestern University.

Her research program focuses on identifying mechanisms of resistance to breast-cancer therapies and on the development of new therapies with a specific focus on triple negative breast cancer.

Faculty Appointments

Professor - Department of Medicine (SMD)

Chair - Department of Medicine (SMD)

Charles Ayrault Dewey Professorship of Medicine - Department of Medicine (SMD)

Professor - Cancer Center - Joint

Connect with Ruth M. O'Regan, M.D.

Credentials

Residency & Fellowship

Residency, Internal Medicine, McGaw Medical Center of Northwestern University. 1998 - 1999

Fellowship, Hematology & Oncology, McGaw Medical Center of Northwestern University. 1995 - 1998

Internship, Internal Medicine, Medical College of Wisconsin. 1994 - 1995

Fellowship, Oncology, Mater Misericordiae University Hospital (Ireland). 1992 - 1994

Fellowship, Internal Medicine, Mease Hospital Dunedin. 1991 - 1992

Residency, Internal Medicine, Mater Misericordiae University Hospital (Ireland). 1988 - 1991

Education

MBBCH | University College Dublin (Republic of Ireland). 1988

Research

Clinical Trials

An Open Label, Phase II Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in Triple Positive Breast Cancers Hoosier Cancer Research Network BRE17-141

Lead Researcher: Ruth M O'Regan

Patient will be treated with neratinib, an aromatase inhibitor and trastuzumab for 24 weeks prior to surgery, following an initial 3 weeks of neratinib alone, aromatase inhibitor alone or the combination of neratinib and an aromatase inhibitor. A bre...

A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination With Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BRE15-024,A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination With Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BRE15-024

Lead Researcher: Ruth M O'Regan

This is an open label, multi-institutional, single arm phase II trial of ribociclib in combination with bicalutamide in advanced AR+ triple-negative breast cancer. No randomization or blinding is involved.

Publications

Journal Articles

Tolaney SM, Kalinsky K, Kaklamani V, D'Adamo DR, Aktan G, Tsai ML, O'Regan RM, Kaufman PA, Wilks ST, Andreopoulou E, Patt DA, Yuan Y, Wang G, Savulsky C, Xing D, Kleynerman E, Karantza V, Diab S

Clinical cancer research : an official journal of the American Association for Cancer Research.. 2021 June 127 (11):3061-3068. Epub 03/16/2021.

Anthony L, Atweh G, Bhatia R, Carey LA, Chang JC, Edelman MJ, Kantoff PW, Markham MJ, Messersmith W, Nelson EL, Oettel K, O'Regan R, Verschraegen CF, Vose JM

JCO oncology practice.. 2021 March 17 (3):e440-e444. Epub 09/30/2020.

Dudek AZ, Liu LC, Fischer JH, Wiley EL, Sachdev JC, Bleeker J, Hurley RW, Tonetti DA, Thatcher GRJ, Venuti RP, O'Regan RM

Breast cancer research and treatment.. 2020 October 183 (3):617-627. Epub 07/22/2020.

Zhao J, Meisel J, Guo Y, Nahta R, Hsieh KL, Peng L, Wei Z, O'Regan R, Li X

Breast cancer research and treatment.. 2020 October 183 (3):599-606. Epub 07/26/2020.

Khuri FR, O'Regan RM

Cancer.. 2020 August 15126 Suppl 16 :3809-3810. Epub 1900 01 01.

Anandan A, Sharifi M, O'Regan R

Current treatment options in oncology.. 2020 August 1521 (10):84. Epub 08/15/2020.

Lin NU, Borges V, Anders C, Murthy RK, Paplomata E, Hamilton E, Hurvitz S, Loi S, Okines A, Abramson V, Bedard PL, Oliveira M, Mueller V, Zelnak A, DiGiovanna MP, Bachelot T, Chien AJ, O'Regan R, Wardley A, Conlin A, Cameron D, Carey L, Curigliano G, Gelmon K, Loibl S, Mayor J, McGoldrick S, An X, Winer EP

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2020 August 1038 (23):2610-2619. Epub 05/29/2020.

Sharifi MN, Anandan A, Grogan P, O'Regan RM

Cancer.. 2020 August 1126 (15):3400-3416. Epub 05/19/2020.

Hennes ER, Reed M, Mably M, Jared J, Bergsbaken JJ, Deming D, Callander N, O'Regan R

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.. 2020 July 2377 (15):1243-1248. Epub 1900 01 01.

Gradishar WJ, Anderson BO, Abraham J, Aft R, Agnese D, Allison KH, Blair SL, Burstein HJ, Dang C, Elias AD, Giordano SH, Goetz MP, Goldstein LJ, Isakoff SJ, Krishnamurthy J, Lyons J, Marcom PK, Matro J, Mayer IA, Moran MS, Mortimer J, O'Regan RM, Patel SA, Pierce LJ, Rugo HS, Sitapati A, Smith KL, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Ward JH, Young JS, Burns JL, Kumar R

Journal of the National Comprehensive Cancer Network : JNCCN.. 2020 April 18 (4):452-478. Epub 1900 01 01.

Zhang S, O'Regan R, Xu W

Cancer.. 2020 March 1126 (5):939-948. Epub 12/23/2019.

Meisel JL, Zhao J, Suo A, Zhang C, Wei Z, Taylor C, Aneja R, Krishnamurti U, Li Z, Nahta R, O'Regan R, Li X

Clinical breast cancer.. 2020 February 20 (1):19-24. Epub 09/18/2019.

Fatima I, El-Ayachi I, Playa HC, Alva-Ornelas JA, Khalid AB, Kuenzinger WL, Wend P, Pence JC, Brakefield L, Krutilina RI, Johnson DL, O'Regan RM, Seewaldt V, Seagroves TN, Krum SA, Miranda-Carboni GA

Cancers.. 2019 December 1711 (12)Epub 12/17/2019.

Meisel JL, O'Regan RM

Cancer.. 2019 September 15125 (18):3104-3106. Epub 06/17/2019.

Arciero CA, Guo Y, Jiang R, Behera M, O'Regan R, Peng L, Li X

Clinical breast cancer.. 2019 August 19 (4):236-245. Epub 02/14/2019.

Paplomata E, Zelnak A, Santa-Maria CA, Liu Y, Gogineni K, Li X, Moreno CS, Chen Z, Kaklamani V, O'Regan RM

Clinical breast cancer.. 2019 June 19 (3):188-196. Epub 01/03/2019.

El Ayachi I, Fatima I, Wend P, Alva-Ornelas JA, Runke S, Kuenzinger WL, Silva J, Silva W, Gray JK, Lehr S, Barch HC, Krutilina RI, White AC, Cardiff R, Yee LD, Yang L, O'Regan RM, Lowry WE, Seagroves TN, Seewaldt V, Krum SA, Miranda-Carboni GA

Cancer research.. 2019 March 179 (5):982-993. Epub 12/18/2018.

Goetz MP, Gradishar WJ, Anderson BO, Abraham J, Aft R, Allison KH, Blair SL, Burstein HJ, Dang C, Elias AD, Farrar WB, Giordano SH, Goldstein LJ, Isakoff SJ, Lyons J, Marcom PK, Mayer IA, Moran MS, Mortimer J, O'Regan RM, Patel SA, Pierce LJ, Reed EC, Rugo HS, Sitapati A, Smith KL, Smith ML, Soliman H, Telli ML, Ward JH, Young JS, Shead DA, Kumar R

Journal of the National Comprehensive Cancer Network : JNCCN.. 2019 February 17 (2):118-126. Epub 1900 01 01.

Kalinsky K, O'Regan RM

Cancer.. 2019 January 15125 (2):177-180. Epub 11/02/2018.

Thompson MA, O'Regan RM

Cancer.. 2018 December 15124 (24):4618-4621. Epub 10/19/2018.

Meisel J, Zhang C, Neely C, Mendoza P, You S, Han T, Liu Y, Sahin AA, O'Regan R, Li X

Clinical breast cancer.. 2018 October 18 (5):347-352. Epub 12/14/2017.

O'Regan RM, Nahta R

Biochemical pharmacology.. 2018 August 154 :407-413. Epub 05/31/2018.

Denduluri N, Miller K, O'Regan RM

American Society of Clinical Oncology educational book. 2018 May 2338 :47-55. Epub 1900 01 01.

Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz MP, Goldstein LJ, Isakoff SJ, Lyons J, Marcom PK, Mayer IA, McCormick B, Moran MS, O'Regan RM, Patel SA, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Sitapati A, Smith KL, Smith ML, Soliman H, Somlo G, Telli ML, Ward JH, Kumar R, Shead DA

Journal of the National Comprehensive Cancer Network : JNCCN.. 2018 March 16 (3):310-320. Epub 1900 01 01.

Miller-Kleinhenz J, Guo X, Qian W, Zhou H, Bozeman EN, Zhu L, Ji X, Wang YA, Styblo T, O'Regan R, Mao H, Yang L

Biomaterials.. 2018 January 152 :47-62. Epub 10/21/2017.

Di Leo A, Johnston S, Lee KS, Ciruelos E, Lønning PE, Janni W, O'Regan R, Mouret-Reynier MA, Kalev D, Egle D, Cs?szi T, Bordonaro R, Decker T, Tjan-Heijnen VCG, Blau S, Schirone A, Weber D, El-Hashimy M, Dharan B, Sellami D, Bachelot T

The Lancet. Oncology.. 2018 January 19 (1):87-100. Epub 12/07/2017.

Shah R, O'Regan RM

Cancer treatment and research.. 2018 173 :15-29. Epub 1900 01 01.

Arciero CA, Yang J, Peng L, Ward KC, O'Regan R, Sahin AA, Li X

Breast cancer research and treatment.. 2017 December 166 (3):743-755. Epub 08/30/2017.

Li X, Yang J, Krishnamurti U, Huo L, Ward KC, O'Regan R, Peng L

Clinical breast cancer.. 2017 August 17 (5):356-366. Epub 04/28/2017.

Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz MP, Goldstein LJ, Isakoff SJ, Lyons J, Marcom PK, Mayer IA, McCormick B, Moran MS, O'Regan RM, Patel SA, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Sitapati A, Smith KL, Smith ML, Soliman H, Somlo G, Telli M, Ward JH, Shead DA, Kumar R

Journal of the National Comprehensive Cancer Network : JNCCN.. 2017 April 15 (4):433-451. Epub 1900 01 01.

Rahim B, O'Regan R

Cancers.. 2017 February 249 (3)Epub 02/24/2017.

Rampurwala M, Wisinski KB, Burkard ME, Ehsani S, O'Regan RM, Carmichael L, Kim K, Kolesar J, Tevaarwerk AJ

Investigational new drugs.. 2017 February 35 (1):87-94. Epub 11/08/2016.

Li X, Yang J, Peng L, Sahin AA, Huo L, Ward KC, O'Regan R, Torres MA, Meisel JL

Breast cancer research and treatment.. 2017 January 161 (2):279-287. Epub 11/25/2016.

Tevaarwerk AJ, Wisinski KB, O'Regan RM

Journal of oncology practice. 2016 November 12 (11):1148-1156. Epub 1900 01 01.

André F, Hurvitz S, Fasolo A, Tseng LM, Jerusalem G, Wilks S, O'Regan R, Isaacs C, Toi M, Burris H, He W, Robinson D, Riester M, Taran T, Chen D, Slamon D

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2016 June 2034 (18):2115-24. Epub 04/18/2016.

Li XB, Krishnamurti U, Bhattarai S, Klimov S, Reid MD, O'Regan R, Aneja R

American journal of clinical pathology.. 2016 June 145 (6):871-8. Epub 06/12/2016.

Strauss WM, Carter C, Simmons J, Klem E, Goodman N, Vahidi B, Romero J, Masterman-Smith M, O'Regan R, Gogineni K, Schwartzberg L, Austin LK, Dempsey PW, Cristofanilli M

Oncotarget.. 2016 May 37 (18):26724-38. Epub 1900 01 01.

Rampurwala M, Wisinski KB, O'Regan R

Clinical advances in hematology & oncology : H&O.. 2016 March 14 (3):186-93. Epub 1900 01 01.

Zelnak AB, O'Regan RM

Journal of the National Comprehensive Cancer Network : JNCCN.. 2015 August 13 (8):e56-64. Epub 1900 01 01.

Dietze EC, Sistrunk C, Miranda-Carboni G, O'Regan R, Seewaldt VL

Nature reviews. Cancer.. 2015 April 15 (4):248-54. Epub 02/12/2015.

Taliaferro-Smith L, Oberlick E, Liu T, McGlothen T, Alcaide T, Tobin R, Donnelly S, Commander R, Kline E, Nagaraju GP, Havel L, Marcus A, Nahta R, O'Regan R

Oncotarget.. 2015 March 106 (7):4757-72. Epub 1900 01 01.

Paplomata E, Nahta R, O'Regan RM

Cancer.. 2015 February 15121 (4):517-26. Epub 10/24/2014.

Zelnak AB, Nikolinakos P, Srinivasiah J, Jonas W, Pippas A, Liu Y, Li X, Torres M, O'Regan RM,

Clinical breast cancer.. 2015 February 15 (1):31-6. Epub 06/24/2014.

Brawley OW, O'Regan RM

Cancer.. 2014 September 15120 (18):2800-2. Epub 06/12/2014.

Liu D, Xiong H, Ellis AE, Northrup NC, Rodriguez CO, O'Regan RM, Dalton S, Zhao S

Cancer research.. 2014 September 1574 (18):5045-56. Epub 07/31/2014.

Shulman LN, Berry DA, Cirrincione CT, Becker HP, Perez EA, O'Regan R, Martino S, Shapiro CL, Schneider CJ, Kimmick G, Burstein HJ, Norton L, Muss H, Hudis CA, Winer EP

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2014 August 132 (22):2311-7. Epub 06/16/2014.

Paplomata E, O'Regan R

Therapeutic advances in medical oncology.. 2014 July 6 (4):154-66. Epub 1900 01 01.

André F, O'Regan R, Ozguroglu M, Toi M, Xu B, Jerusalem G, Masuda N, Wilks S, Arena F, Isaacs C, Yap YS, Papai Z, Lang I, Armstrong A, Lerzo G, White M, Shen K, Litton J, Chen D, Zhang Y, Ali S, Taran T, Gianni L

The Lancet. Oncology.. 2014 May 15 (6):580-91. Epub 04/14/2014.

Jacob Arriola KR, Mason TA, Bannon KA, Holmes C, Powell CL, Horne K, O'Regan R

Patient education and counseling.. 2014 April 95 (1):98-103. Epub 01/10/2014.

Xu J, Agyemang S, Qin Y, Aysola K, Giles M, Oprea G, O'Regan RM, Partridge EE, Harris-Hooker S, Rice VM, Reddy ES, Rao VN

Enliven. Challenges in cancer detection and therapy.. 2014 1 (1)Epub 1900 01 01.

Hurvitz SA, Dalenc F, Campone M, O'Regan RM, Tjan-Heijnen VC, Gligorov J, Llombart A, Jhangiani H, Mirshahidi HR, Tan-Chiu E, Miao S, El-Hashimy M, Lincy J, Taran T, Soria JC, Sahmoud T, André F

Breast cancer research and treatment.. 2013 October 141 (3):437-46. Epub 10/08/2013.

Paplomata E, Zelnak A, O'Regan R

Breast cancer research and treatment.. 2013 August 140 (3):453-62. Epub 08/02/2013.

Hagen KR, Zeng X, Lee MY, Tucker Kahn S, Harrison Pitner MK, Zaky SS, Liu Y, O'Regan RM, Deng X, Saavedra HI

Cell division. 2013 July 258 (1):10. Epub 07/25/2013.

Zelnak AB, Styblo TM, Rizzo M, Gabram SG, Wood WC, Harichand-Herdt S, Kim S, Liu Y, O'Regan RM,

Clinical breast cancer.. 2013 June 13 (3):173-9. Epub 01/16/2013.

Zelnak AB, O'Regan RM

Oncology.. 2013 March 27 (3):204-10. Epub 1900 01 01.

Habtes I, Friedman D, Raskind-Hood C, Adams K, Becker ER, D'Orsi C, Birdsong G, Gundry K, O'Regan R, Gabram SG

Cancer.. 2013 February 1119 (3):481-7. Epub 08/01/2012.

Paplomata E, O'Regan R

Therapeutics and clinical risk management.. 2013 9 :27-36. Epub 01/14/2013.

Marcus DM, Switchenko JM, Prabhu R, O'Regan R, Zelnak A, Fasola C, Mister D, Torres MA

Frontiers in oncology.. 2013 3 :317. Epub 12/27/2013.

Shulman LN, Cirrincione CT, Berry DA, Becker HP, Perez EA, O'Regan R, Martino S, Atkins JN, Mayer E, Schneider CJ, Kimmick G, Norton L, Muss H, Winer EP, Hudis C

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2012 November 2030 (33):4071-6. Epub 07/23/2012.

Nahta R, O'Regan RM

Breast cancer research and treatment.. 2012 August 135 (1):39-48. Epub 04/20/2012.

Zhao P, Nairn AV, Hester S, Moremen KW, O'Regan RM, Oprea G, Wells L, Pierce M, Abbott KL

The Journal of biological chemistry.. 2012 July 20287 (30):25230-40. Epub 05/31/2012.

Prabhu R, Godette K, Carlson G, Losken A, Gabram S, Fasola C, O'Regan R, Zelnak A, Torres M

International journal of radiation oncology, biology, physics.. 2012 March 1582 (4):e587-93. Epub 12/22/2011.

O'Regan R

Clinical advances in hematology & oncology : H&O.. 2012 March 10 (3):187-9. Epub 1900 01 01.

Lund MJ, Mosunjac M, Davis KM, Gabram-Mendola S, Rizzo M, Bumpers HL, Hearn S, Zelnak A, Styblo T, O'Regan RM

Cancer.. 2012 February 1118 (3):788-96. Epub 06/30/2011.

Gayle SS, Arnold SL, O'Regan RM, Nahta R

Anti-cancer agents in medicinal chemistry.. 2012 February 12 (2):151-62. Epub 1900 01 01.

Mitri Z, Constantine T, O'Regan R

Chemotherapy research and practice. 2012 2012 :743193. Epub 12/20/2012.

Andic F, Godette K, O'Regan R, Zelnak A, Liu T, Rizzo M, Gabram S, Torres M

Cancer.. 2011 December 15117 (24):5485-92. Epub 06/20/2011.

Zaky SS, Lund M, May KA, Godette KD, Beitler JJ, Holmes LR, O'Regan RM, Yu ES, Yu DS, Landry JC

Annals of surgical oncology.. 2011 October 18 (10):2858-65. Epub 03/26/2011.

Liu T, Yacoub R, Taliaferro-Smith LD, Sun SY, Graham TR, Dolan R, Lobo C, Tighiouart M, Yang L, Adams A, O'Regan RM

Molecular cancer therapeutics.. 2011 August 10 (8):1460-9. Epub 06/20/2011.

O'Regan R, Hawk NN

Expert opinion on therapeutic targets.. 2011 July 15 (7):859-72. Epub 04/08/2011.

O'Regan R

Oncology.. 2011 February 25 (2):140, 142. Epub 1900 01 01.

Rizzo M, Bumpers H, Okoli J, Senior-Crosby D, O'Regan R, Zelnak A, Pan L, Mosunjac M, Patterson SG, Gabram SG

Annals of surgical oncology.. 2011 January 18 (1):34-9. Epub 07/13/2010.

Andre F, Campone M, O'Regan R, Manlius C, Massacesi C, Sahmoud T, Mukhopadhyay P, Soria JC, Naughton M, Hurvitz SA

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2010 December 128 (34):5110-5. Epub 10/25/2010.

Harichand-Herdt S, O'regan RM

American journal of clinical oncology.. 2010 December 33 (6):561-7. Epub 1900 01 01.

Nahta R, O'Regan RM

Clinical breast cancer.. 2010 November 10 Suppl 3 :S72-8. Epub 1900 01 01.

Graham TR, Yacoub R, Taliaferro-Smith L, Osunkoya AO, Odero-Marah VA, Liu T, Kimbro KS, Sharma D, O'Regan RM

Breast cancer research and treatment.. 2010 August 123 (1):139-47. Epub 11/18/2009.

Lund MJ, Butler EN, Hair BY, Ward KC, Andrews JH, Oprea-Ilies G, Bayakly AR, O'Regan RM, Vertino PM, Eley JW

Cancer.. 2010 June 1116 (11):2549-59. Epub 1900 01 01.

Ozbay T, Durden DL, Liu T, O'Regan RM, Nahta R

Cancer chemotherapy and pharmacology.. 2010 March 65 (4):697-706. Epub 07/28/2009.

Kaklamani VG, Cianfrocca M, Ciccone J, Kindy K, Rademaker A, Wiley EL, Gradishar W, O'Regan RM

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.. 2010 March 15 (2):191-3. Epub 1900 01 01.

Iyengar R, Lund MJ, Lamson P, Holmes L, Rizzo M, Bumpers H, Okoli J, Senior-Crosby D, O'Regan R, Gabram SG

The breast journal.. 2010 16 (3):240-4. Epub 04/12/2010.

O'Regan RM

The Lancet. Oncology.. 2009 December 10 (12):1132-3. Epub 11/10/2009.

Rowe DL, Ozbay T, O'Regan RM, Nahta R

Breast cancer : basic and clinical research.. 2009 September 23 :61-75. Epub 09/02/2009.

Rizzo M, Lund MJ, Mosunjac M, Bumpers H, Holmes L, O'Regan R, Brawley OW, Gabram S

Cancer.. 2009 July 1115 (13):3009-15. Epub 1900 01 01.

Harichand-Herdt S, Zelnak A, O'Regan R

Expert review of anticancer therapy.. 2009 February 9 (2):187-98. Epub 1900 01 01.

Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, Flagg EW, O'Regan RM, Gabram SG, Eley JW

Breast cancer research and treatment.. 2009 January 113 (2):357-70. Epub 03/07/2008.

Yezhelyev M, Yacoub R, O'Regan R

Nanomedicine.. 2009 January 4 (1):83-103. Epub 1900 01 01.

Saxena NK, Taliaferro-Smith L, Knight BB, Merlin D, Anania FA, O'Regan RM, Sharma D

Cancer research.. 2008 December 168 (23):9712-22. Epub 1900 01 01.

Yezhelyev MV, Qi L, O'Regan RM, Nie S, Gao X

Journal of the American Chemical Society.. 2008 July 16130 (28):9006-12. Epub 06/21/2008.

Graham TR, Zhau HE, Odero-Marah VA, Osunkoya AO, Kimbro KS, Tighiouart M, Liu T, Simons JW, O'Regan RM

Cancer research.. 2008 April 168 (7):2479-88. Epub 1900 01 01.

Abbott KL, Aoki K, Lim JM, Porterfield M, Johnson R, O'Regan RM, Wells L, Tiemeyer M, Pierce M

Journal of proteome research.. 2008 April 7 (4):1470-80. Epub 02/14/2008.

Zelnak AB, O'Regan R

Cancer treatment and research.. 2008 141 :63-78. Epub 1900 01 01.

Engel RH, Brown JA, Von Roenn JH, O'Regan RM, Bergan R, Badve S, Rademaker A, Gradishar WJ

Cancer investigation.. 2007 December 25 (8):733-7. Epub 10/18/2007.

Peng XH, Karna P, O'Regan RM, Liu X, Naithani R, Moriarty RM, Wood WC, Lee HY, Yang L

Molecular pharmacology.. 2007 January 71 (1):101-11. Epub 10/11/2006.

Xing Y, Chaudry Q, Shen C, Kong KY, Zhau HE, Chung LW, Petros JA, O'Regan RM, Yezhelyev MV, Simons JW, Wang MD, Nie S

Nature protocols.. 2007 2 (5):1152-65. Epub 1900 01 01.

Zelnak AB, O'Regan RM

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.. 2007 21 (4):209-14. Epub 1900 01 01.

Seleverstov O, Zabirnyk O, Zscharnack M, Bulavina L, Nowicki M, Heinrich JM, Yezhelyev M, Emmrich F, O'Regan R, Bader A

Nano letters.. 2006 December 6 (12):2826-32. Epub 1900 01 01.

Yezhelyev MV, Gao X, Xing Y, Al-Hajj A, Nie S, O'Regan RM

The Lancet. Oncology.. 2006 August 7 (8):657-67. Epub 1900 01 01.

O'Regan RM

Lancet.. 2006 April 29367 (9520):1382-3. Epub 1900 01 01.

O'Regan RM, Osipo C, Ariazi E, Lee ES, Meeke K, Morris C, Bertucci A, Sarker MA, Grigg R, Jordan VC

Clinical cancer research : an official journal of the American Association for Cancer Research.. 2006 April 112 (7 Pt 1):2255-63. Epub 1900 01 01.

Al-Hajj A, O'Regan R

Current treatment options in oncology.. 2006 March 7 (2):153-65. Epub 1900 01 01.

O'Regan R

ACP journal club.. 2006 144 (2):39. Epub 1900 01 01.

O'Regan RM, Von Roenn JH, Carlson RW, Malik U, Sparano JA, Staradub V, Khan S, Jovanovic B, Morrow M, Gradishar WJ

Clinical breast cancer.. 2005 June 6 (2):163-8. Epub 1900 01 01.

Kudachadkar R, O'Regan RM

CA: a cancer journal for clinicians.. 2005 55 (3):145-63. Epub 1900 01 01.

Kim G, O'regan R, Nie S

Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society.. 2005 2006 :714-6. Epub 1900 01 01.

O'Regan RM

JAMA.. 2004 September 1292 (9):1062-3. Epub 1900 01 01.

Kaklamani V, O'Regan RM

Seminars in oncology.. 2004 April 31 (2 Suppl 4):20-5. Epub 1900 01 01.

Zelnak AB, O'Regan RM

Current problems in cancer.. 2004 28 (4):201-17. Epub 1900 01 01.

Shah AP, Parmar S, O'Regan R

Journal of cardiovascular pharmacology and therapeutics.. 2003 December 8 (4):307-11. Epub 1900 01 01.

Gradishar WJ, O'Regan RM

International journal of clinical oncology.. 2003 August 8 (4):239-47. Epub 1900 01 01.

Dardes RC, O'Regan RM, Gajdos C, Robinson SP, Bentrem D, De Los Reyes A, Jordan VC

Clinical cancer research : an official journal of the American Association for Cancer Research.. 2002 June 8 (6):1995-2001. Epub 1900 01 01.

O'Regan RM, Jordan VC

The Lancet. Oncology.. 2002 April 3 (4):207-14. Epub 1900 01 01.

O'Regan RM, Gajdos C, Dardes RC, De Los Reyes A, Park W, Rademaker AW, Jordan VC

Journal of the National Cancer Institute.. 2002 February 2094 (4):274-83. Epub 1900 01 01.

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. Â鶹ÊÓƵpartners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.